Pharmaceuticals & Medical Devices
Featured news
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has launched today its calculator for fair medicines prices in Europe (German version here). The calculator transposes AIM's fair pricin......
Recommendations towards fair medicines prices in Europe
12 European and international organisations representing not-for-profit healthcare insurers, healthcare professionals, public interest organisations and trade unions have developed and endorsed recomm......
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe. AIM calls for the European Pharmaceutical Str......
Other news
AMR: an ambitious European Plan to tackle an urging global Challenge
AIM, the International Association of Mutual Benefit Societies, welcom...
“A step in the right direction but a more ambitious final legislation is needed” – Mutuals react to the publication of the general pharmaceutical legislation proposal
The much-awaited proposal of the European Commission, aimed at reformi...
“Our health before profit” – Our Belgian member Solidaris launches a campaign to integrate fair pricing of medicinal products in the legislation
Our Belgian member Solidaris, the socialist mutual, launched its campa...
AIM participates in the kick-off of the ASCERTAIN Horizon Europe project
On 24 and 25 January, AIM participated in the kick-off meeting of the...
AIM is part of the ASCERTAIN project to secure access to affordable medicinal products to European patients
AIM participates in a European project on affordability of medicinal p...
Joint Statement on the Revision of the Pharmaceutical Legislation by associations representing healthcare providers, patients, healthcare professionals and payers
Enhancing patients’ access to high-quality and affordable medicinal...
“Better treatment for better health: lifting the veil on treatment optimisation” – Stakeholders exchange views on patient-centred clinical research at EORTC and AIM’s seminar
Treatment optimisation is defined as clinical research in real-world c...
European Commission opens its public consultation on the revision of the basic pharmaceutical legislation
On 28 September the European Commission opened its public consultation...
Payer involvement is important for a successful EU HTA framework!
The International Association of Mutual Benefit Societies (AIM) welcom...